California State Teachers Retirement System (CalSTRS)
ADVM

California State Teachers Retirement System (CalSTRS)’s Adverum Biotechnologies ADVM Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,507
Closed -$6.59K – 2963
2025
Q1 		$6.59K Hold
1,507
– – ﹤0.01% 2871
2024
Q4 		$7.04K Hold
1,507
– – ﹤0.01% 2949
2024
Q3 		$10.6K Hold
1,507
– – ﹤0.01% 2861
2024
Q2 		$10.3K Buy
+1,507
New +$14K ﹤0.01% 2886
2022
Q2 		– Sell
-3,742
Closed -$49K – 3128
2022
Q1 		$49K Sell
3,742
-962
-20% -$14.1K ﹤0.01% 3038
2021
Q4 		$83K Sell
4,704
-4,797
-50% -$96K ﹤0.01% 3060
2021
Q3 		$206K Sell
9,501
-2,481
-21% -$63.3K ﹤0.01% 2731
2021
Q2 		$419K Sell
11,982
-1,440
-11% -$77.6K ﹤0.01% 2745
2021
Q1 		$1.32M Sell
13,422
-41
-0.3% -$4.92K ﹤0.01% 1968
2020
Q4 		$1.46M Buy
13,463
+310
+2% +$38.4K ﹤0.01% 1809
2020
Q3 		$1.35M Buy
13,153
+2,142
+19% +$321K ﹤0.01% 1715
2020
Q2 		$2.3M Buy
11,011
+1,401
+15% +$248K ﹤0.01% 1393
2020
Q1 		$939K Buy
9,610
+1,365
+17% +$159K ﹤0.01% 1708
2019
Q4 		$950K Sell
8,245
-330
-4% -$29.1K ﹤0.01% 1997
2019
Q3 		$467K Buy
8,575
+396
+5% +$44.6K ﹤0.01% 2339
2019
Q2 		$972K Sell
8,179
-208
-2% -$17.2K ﹤0.01% 1985
2019
Q1 		$439K Hold
8,387
– – ﹤0.01% 2377
2018
Q4 		$264K Hold
8,387
– – ﹤0.01% 2632
2018
Q3 		$507K Buy
8,387
+55
+0.7% +$3.09K ﹤0.01% 2447
2018
Q2 		$442K Buy
+8,332
New +$501K ﹤0.01% 2517
2017
Q2 		– Sell
-4,724
Closed -$128K – 3009
2017
Q1 		$128K Sell
4,724
-80
-2% -$2.27K ﹤0.01% 2902
2016
Q4 		$139K Sell
4,804
-70
-1% -$2.29K ﹤0.01% 2923
2016
Q3 		$200K Buy
4,874
+50
+1% +$1.9K ﹤0.01% 2867
2016
Q2 		$152K Buy
4,824
+685
+17% +$30.9K ﹤0.01% 2949
2016
Q1 		$214K Buy
4,139
+516
+14% +$28.8K ﹤0.01% 2781
2015
Q4 		$345K Buy
3,623
+63
+2% +$5.54K ﹤0.01% 2641
2015
Q3 		$293K Sell
3,560
-10
-0.3% -$1.28K ﹤0.01% 2748
2015
Q2 		$580K Buy
3,570
+2,165
+154% +$730K ﹤0.01% 2455
2015
Q1 		$569K Buy
1,405
+130
+10% +$55K ﹤0.01% 2369
2014
Q4 		$689K Buy
1,275
+5
+0.4% +$1.93K ﹤0.01% 2292
2014
Q3 		$434K Buy
+1,270
New +$378K ﹤0.01% 2517

Other funds holding ADVM

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s ADVM Position: Q2 2025 in Review

California State Teachers Retirement System (CalSTRS) sold out of Adverum Biotechnologies (ADVM) in Q2 2025, closing a stake of 1,507 shares — an estimated $6.59K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in ADVM in Q3 2014 and held it in 31 quarters. The position peaked at $2.3M in Q2 2020. 58 funds tracked by Wall St. Rank hold ADVM as of Q2 2025.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Adverum Biotechnologies position as of Q2 2025 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 1,507 Adverum Biotechnologies shares in Q2 2025, an estimated $6.59K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Adverum Biotechnologies in Q3 2014 and held it in 31 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Adverum Biotechnologies position peaked at $2.3M in Q2 2020.
  • 58 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2025.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2025, filed 14 Aug 2025.